RecruitingNCT06611020
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Enrollment
600 participants
Start Date
Jan 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria1
- Treatment of HPV-related disease
Exclusion Criteria1
- Previous HPV vaccination
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06611020
Related Trials
Point of Care - Triage and Treatment for Cervical Pre-cancer
NCT074618181 location
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
NCT047128511 location
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
NCT068159391 location
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NCT072753331 location
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
NCT061911331 location